Health

Home care company Tomorrow Health just scored $60M, but the outlook for the rest of the year looks gloomy for Tomorrow and its peers as investors caution amid economic uncertainty.

AliveCor’s tech could be a more accessible option for clinical research as the ITC weighs a ban of Apple Watches after an EKG patent violation.

Health tech companies have reeled in billions in VC funding with promises to boost health outcomes and lower costs—but a new study sheds light on the lack of clinical outcomes they actually generate.

Ro is the latest startup to lay off a large chunk of its employee base amid economic uncertainty and fewer VC funding hauls.

Virtual doctors say pets, family, and bathroom breaks make some telehealth visit difficult

That counters Medicare, which has seen drug prices increase more rapidly than inflation—and patients can’t keep up.

We combed through The Markup report about 33 US hospital websites sending patient info to Facebook and unpack why they could face HIPAA violations.

Both retail giants now have clinical trial businesses as Walgreens announces its entrance into the clinical trial space. But CVS can use Aetna to tap millions of additional patients.

Remote surgery platform Proximie raised $80M. We unpack how it solves typical telehealth connectivity barriers and why more US health systems are becoming interested in the tech.

Doctor search and booking company Sesame Health raised $27M as patients lose loyalty to physicians—especially if they have lousy ratings online.

We unpack data from a new Walmart-powered healthcare provider survey and detail how the findings fit into Walmart’s broader rural healthcare strategy.

Teladoc got slapped with a lawsuit alleging it misled investors about its 2022 financial expectations. Fewer COVID-19 concerns and increasing competition could be driving losses.

New data reveals teletherapists are less likely to offer services to Medicaid beneficiaries than Medicare patients post-pandemic. We detail what it means for the future of Medicaid.

MindMaze has plans to validate its latest digital therapy for stroke intervention in the US. We detail why its new AMA codes could help it stand out to clinicians.